The Food and Drug Administration (FDA) today approved Dovato (dolutegravir and lamivudine), as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults with no antiretroviral treatment history and...
An analysis led by ISGlobal identifies African regions where ivermectin administration to livestock would have the greatest impact on malaria transmission. The results, published, in Scientific Reports, point to West Africa, below the Sahel, where...
There is little chance you are actually allergic to vaccines and, if you are, your allergist can give it to you. Only 1 in 760,000 vaccinations will respond with anaphylaxis. For all other side effects, there are ways around any problem...
In a new series of articles, experts in immunology, virology, epidemiology, and vaccine development detail efforts to improve seasonal influenza vaccines and ultimately develop a universal influenza vaccine. The 15 articles are part of a...
Among continued efforts to reduce maternal morbidity and mortality, the Society for Maternal-Fetal Medicine (SMFM) released new recommendations related to the diagnosis and treatment of sepsis. The "SMFM Consult Series 47: Sepsis During Pregnancy...
Each year at least 2 million Americans are infected with bacteria that cannot be treated with antibiotics, and at least 23,000 of these people die, according to the Centers for Disease Control...
A team of Colorado State University researchers has developed technology that can detect extremely small amounts of antibodies in a person's blood. Antibodies develop to infect cells or kill pathogens, essentially fighting off a bacteria or virus...
Hundreds of different bacterial species are living inside your mouth. Some are highly abundant, while others are scarce. A few of these oral bacteria are known pathogens. Others are benign, or even beneficial...
Dangerous airborne viruses are rendered harmless on-the-fly when exposed to energetic, charged fragments of air molecules, University of Michigan researchers have shown...
